Biotech: Why Health Insurance Charges Are Going Up

Having trouble reading this e-mail? Click here for mobile version.

FORBES.COM BIOTECH NEWSLETTER NOVEMBER 04, 2009
Why Health Insurance Charges Are Going Up David Whelan Despite strong earnings, HMOs are planning steep premium increases for next year. Genomics: No Longer A Failure Matthew Herper and Robert Langreth Mapping the human genome produced far more hype than drugs. That's starting to change. Amgen's Anemic Results Robert Langreth The company's best-selling Aranesp drug doubles the risk that kidney patients will suffer a stroke. Living Without Blockbusters Matthew Herper Sanofi-Aventis' Christopher Viehbacher is slashing R&D and moving into emerging countries. Healing Power Andy Stone Ultrasound is said to heal chronic wounds that don't respond to other treatments.	ADVERTISEMENT
Forbes Magazine Special Offer! Forbes.com Newsletter readers receive a Free Trial Issue of Forbes... no risk... no obligation! If you decide to subscribe to Forbes, you can do so at special introductory savings, and get 25 more issues - 26 in all - for just $1.15 a copy. You save 77% off the $4.99 newsstand price. If you decide Forbes is not for you, simply write cancel on the invoice you receive and return it. The FREE issue is yours to keep with our compliments. Sign up Today for your Free Trial Issue! © 2009 Forbes.com LLC.™